Solana's treasury company Artelo Biosciences completes a $3 million equity fundraising after going public in the US stock market

Nasdaq-listed Solana treasury company Artelo Biosciences announced a public offering of 640,924 shares of common stock at a price of $4.4 per share, raising a total of approximately $3 million. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the official launch of a Solana-based digital asset treasury strategy and has invested part of its capital in purchasing SOL tokens, currently holding 45,883 SOL.